Optum CDM is derived from a database of administrative health claims for members of large commercial and Medicare Advantage health plans (UnitedHealth Group Inc., Eden Prairie, MN, US
Theyll assess your medical history and individual circumstances and either issue your prescription or recommend an alternative weight loss treatment
Common adverse effects of GLP-1 receptor agonists include: Gastrointestinal symptoms (nausea, vomiting, diarrhoea, constipation)usually mild to moderate and often diminishing over time Injection site reactions Headache Fatigue More serious but rare adverse effects have been identified, including: Pancreatitis patients should seek urgent medical advice for severe, persistent abdominal pain (with or without vomiting) Gallbladder disease symptoms include upper right abdominal pain and jaundice Diabetic retinopathy complications particularly with rapid HbA1c reduction in patients with pre-existing retinopathy Dehydration and acute kidney injury from persistent gastrointestinal symptoms When combined with sulfonylureas or insulin, GLP-1 receptor agonists increase the risk of hypoglycaemia
The FLOW kidney trial was concluded early
Eligibility: Patients must have commercial drug insurance and a prescription consistent with FDA-approved product labeling